InsiderTrades.com logo
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

TFFP Insider Trading

Insider Ownership Percentage: 4.60%
Insider Buying (Last 12 Months): $4,296,773.00
Insider Selling (Last 12 Months): $172,693.95

TFF Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at TFF Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TFF Pharmaceuticals Share Price & Price History

Current Price: $0.67
Price Change: ▼ Price Decrease of -0.03 (-4.27%)
As of 03/30/2023 01:00 AM ET

This chart shows the closing price history over time for TFFP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

TFF Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/10/2023Harlan F WeismanCEOBuy150,000$0.88$132,000.00214,615View SEC Filing Icon  
3/10/2023Kirk Allen ColemanCFOBuy12,000$0.79$9,480.0015,675View SEC Filing Icon  
3/10/2023Zamaneh MikhakInsiderBuy15,000$0.82$12,300.0015,000View SEC Filing Icon  
12/15/2022Harlan F WeismanCEOBuy50,000$1.06$53,000.0064,615View SEC Filing Icon  
11/22/2022Aaron G.L. FletcherDirectorBuy43,470$1.15$49,990.50143,470View SEC Filing Icon  
9/29/2022Randy H. ThurmanDirectorSell40,255$4.29$172,693.95View SEC Filing Icon  
5/20/2022Harlan F WeismanDirectorBuy4,615$5.50$25,382.5014,615View SEC Filing Icon  
5/18/2022Harlan F WeismanDirectorBuy2,500$5.12$12,800.0010,000View SEC Filing Icon  
5/16/2022Aaron G.L. FletcherDirectorBuy85,000$4.86$413,100.0085,000View SEC Filing Icon  
5/16/2022Glenn R. MattesCEOBuy16,000$4.78$76,480.0036,000View SEC Filing Icon  
5/16/2022Kirk Allen ColemanCFOBuy1,250$4.40$5,500.003,250View SEC Filing Icon  
4/4/2022Aaron G.L. FletcherDirectorBuy542,000$6.47$3,506,740.00100,000View SEC Filing Icon  
9/16/2021Glenn R. MattesCEOBuy10,000$7.10$71,000.0020,000View SEC Filing Icon  
9/16/2021Kirk Allen ColemanCFOBuy1,000$7.30$7,300.00View SEC Filing Icon  
5/19/2021Malcolm FairbairnDirectorBuy10,000$8.95$89,500.00
3/26/2021Lung Therapeutics, Inc.Major ShareholderSell715,000$14.00$10,010,000.002,235,000View SEC Filing Icon  
3/15/2021Glenn R. MattesCEOSell50,000$17.04$852,000.0060,000View SEC Filing Icon  
3/15/2021Kirk Allen ColemanCFOSell5,000$17.05$85,250.006,000View SEC Filing Icon  
3/15/2021Stephen RocamboliDirectorSell20,006$16.85$337,101.1030,478View SEC Filing Icon  
1/19/2021Robert S MillsDirectorSell55,100$19.56$1,077,756.0071,080View SEC Filing Icon  
1/15/2021Glenn R. MattesCEOSell40,000$17.51$700,400.0050,000View SEC Filing Icon  
1/15/2021Kirk Allen ColemanCFOSell5,000$17.50$87,500.006,000View SEC Filing Icon  
12/23/2020Glenn R. MattesCEOSell30,000$15.33$459,900.0040,000View SEC Filing Icon  
12/23/2020Kirk Allen ColemanCFOSell10,000$15.24$152,400.0011,000View SEC Filing Icon  
12/7/2020James Brian WindsorInsiderSell25,000$15.80$395,000.0030,000View SEC Filing Icon  
12/4/2020Lung Therapeutics, Inc.Major ShareholderSell1,050,000$13.86$14,553,000.003,500,000View SEC Filing Icon  
11/24/2020Aaron G.L. FletcherDirectorBuy5,000$15.13$75,650.00100,000View SEC Filing Icon  
11/13/2020Randy H ThurmanDirectorSell5,000$17.17$85,850.0039,504View SEC Filing Icon  
11/11/2020Malcolm FairbairnDirectorSell63,331$15.93$1,008,862.8321,278View SEC Filing Icon  
11/10/2020Glenn R. MattesCEOSell108,830$15.00$1,632,450.00118,830View SEC Filing Icon  
11/10/2020Kirk Allen ColemanCFOSell15,000$15.12$226,800.0016,000View SEC Filing Icon  
5/26/2020Aaron G.L. FletcherDirectorBuy20,000$5.08$101,600.0095,000View SEC Filing Icon  
4/15/2020Aaron G.L. FletcherDirectorBuy5,581$4.72$26,342.3275,000View SEC Filing Icon  
4/6/2020Aaron G.L. FletcherDirectorBuy6,252$4.24$26,508.4846,419View SEC Filing Icon  
4/2/2020Aaron G.L. FletcherDirectorBuy500$3.75$1,875.0046,419View SEC Filing Icon  
See Full Table
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel

SEC Filings (Institutional Ownership Changes) for TFF Pharmaceuticals (NASDAQ:TFFP)

16.46% of TFF Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TFFP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

TFF Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/16/2023AIGH Capital Management LLC1,739,130$1.83M0.6%N/A4.998%Search for SEC Filing on Google Icon
2/15/2023DRW Securities LLC1,000,000$1.05M0.0%N/A2.874%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC190,047$0.20M0.0%N/A0.546%Search for SEC Filing on Google Icon
2/14/2023Two Sigma Investments LP56,954$60K0.0%N/A0.164%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC72,155$76K0.0%N/A0.207%Search for SEC Filing on Google Icon
2/8/2023UBS Group AG114,071$0.12M0.0%+16.9%0.328%Search for SEC Filing on Google Icon
2/3/2023Sepio Capital LP330,600$0.35M0.0%+4.9%0.950%Search for SEC Filing on Google Icon
1/31/2023Princeton Capital Management LLC101,449$0.11M0.0%-25.7%0.292%Search for SEC Filing on Google Icon
1/24/2023Sigma Planning Corp100,891$0.11M0.0%+31.2%0.290%Search for SEC Filing on Google Icon
11/15/2022Carlson Capital L P275,000$1.12M0.1%-8.3%1.079%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC20,776$84K0.0%N/A0.082%Search for SEC Filing on Google Icon
10/28/2022Sepio Capital LP315,060$1.28M0.1%+222.5%1.237%Search for SEC Filing on Google Icon
8/17/2022Quantum Private Wealth LLC11,082$62K0.0%N/A0.044%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG92,177$0.52M0.0%+12.3%0.363%Search for SEC Filing on Google Icon
8/9/2022Fermata Advisors LLC27,599$0.16M0.1%+15.7%0.109%Search for SEC Filing on Google Icon
8/1/2022Gagnon Securities LLC284,361$1.61M0.3%+12.4%1.121%Search for SEC Filing on Google Icon
7/28/2022Selective Wealth Management Inc.5,000$28K0.0%+100.0%0.020%Search for SEC Filing on Google Icon
7/26/2022Sepio Capital LP97,700$0.55M0.1%N/A0.385%Search for SEC Filing on Google Icon
7/15/2022Westside Investment Management Inc.51,650$0.29M0.0%+11.8%0.204%Search for SEC Filing on Google Icon
5/16/2022PDT Partners LLC18,616$0.12M0.0%-31.3%0.073%Search for SEC Filing on Google Icon
5/16/2022State Street Corp69,929$0.44M0.0%+8.1%0.276%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG82,054$0.52M0.0%-5.6%0.323%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.864,983$5.46M0.0%+6.5%3.409%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP105,388$0.67M0.1%-18.5%0.415%Search for SEC Filing on Google Icon
4/25/2022Westside Investment Management Inc.46,200$0.29M0.0%+133.6%0.182%Search for SEC Filing on Google Icon
2/15/2022Westside Investment Management Inc.19,775$0.18M0.0%N/A0.078%Search for SEC Filing on Google Icon
2/14/2022PDT Partners LLC27,083$0.24M0.0%-18.7%0.107%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP129,241$1.15M0.1%-11.0%0.509%Search for SEC Filing on Google Icon
2/9/2022Princeton Capital Management LLC125,771$1.12M0.3%-1.8%0.496%Search for SEC Filing on Google Icon
2/8/2022Gagnon Securities LLC252,473$2.24M0.3%-10.5%0.995%Search for SEC Filing on Google Icon
2/4/2022IndexIQ Advisors LLC31,121$0.28M0.0%-6.1%0.123%Search for SEC Filing on Google Icon
2/2/2022Fermata Advisors LLC22,435$0.20M0.1%+9.1%0.088%Search for SEC Filing on Google Icon
1/28/2022National Asset Management Inc.31,800$0.28M0.0%+18.7%0.125%Search for SEC Filing on Google Icon
1/27/2022Janney Montgomery Scott LLC259,009$2.30M0.0%+32.4%1.021%Search for SEC Filing on Google Icon
1/20/2022Parallel Advisors LLC2,963$26K0.0%N/A0.012%Search for SEC Filing on Google Icon
1/19/2022Newbridge Financial Services Group Inc.4,000$35K0.0%N/A0.016%Search for SEC Filing on Google Icon
11/16/2021National Asset Management Inc.26,800$0.21M0.0%N/A0.106%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP11,951$92K0.0%N/A0.047%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP145,295$1.12M0.1%+88.0%0.573%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC87,000$0.67M0.0%-52.4%0.343%Search for SEC Filing on Google Icon
11/12/2021Carlson Capital L P227,701$1.76M0.1%+5.9%0.897%Search for SEC Filing on Google Icon
11/12/2021Apis Capital Advisors LLC80,000$0.62M0.6%-52.9%0.315%Search for SEC Filing on Google Icon
11/12/2021Gagnon Securities LLC282,229$2.18M0.3%-38.5%1.112%Search for SEC Filing on Google Icon
11/12/2021MYDA Advisors LLC40,000$0.31M0.1%N/A0.158%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC124,701$0.96M0.0%+2.0%0.491%Search for SEC Filing on Google Icon
11/10/2021IndexIQ Advisors LLC33,132$0.26M0.0%+11.1%0.131%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.259,270$2M0.0%-0.9%1.022%Search for SEC Filing on Google Icon
11/2/2021Raymond James & Associates36,800$0.28M0.0%+65.2%0.145%Search for SEC Filing on Google Icon
10/29/2021Janney Montgomery Scott LLC195,656$1.51M0.0%+22.7%0.771%Search for SEC Filing on Google Icon
10/28/2021Sigma Planning Corp75,900$0.59M0.0%+5.5%0.299%Search for SEC Filing on Google Icon
10/20/2021Mesirow Financial Investment Management Inc.40,005$0.31M0.9%+46.4%0.158%Search for SEC Filing on Google Icon
10/19/2021Assenagon Asset Management S.A.22,515$0.17M0.0%-45.5%0.089%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC113,264$1.09M0.0%-52.7%0.447%Search for SEC Filing on Google Icon
8/17/2021Apis Capital Advisors LLC170,000$1.63M1.4%-6.8%0.670%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC25,300$0.24M0.0%+33.4%0.100%Search for SEC Filing on Google Icon
8/16/2021Nantahala Capital Management LLC367,817$3.54M0.1%-3.9%1.450%Search for SEC Filing on Google Icon
8/16/2021Occudo Quantitative Strategies LP11,901$0.11M0.0%N/A0.047%Search for SEC Filing on Google Icon
8/16/2021First Trust Advisors LP37,350$0.36M0.0%+20.5%0.147%Search for SEC Filing on Google Icon
8/16/2021State Street Corp43,878$0.42M0.0%N/A0.173%Search for SEC Filing on Google Icon
8/16/2021Carlson Capital L P215,000$2.07M0.1%+26.5%0.848%Search for SEC Filing on Google Icon
8/13/2021Renaissance Technologies LLC182,700$1.76M0.0%+182.4%0.720%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp28,042$0.27M0.0%+30.2%0.111%Search for SEC Filing on Google Icon
8/13/2021Sigma Planning Corp71,950$0.69M0.0%+6.0%0.284%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC122,302$1.18M0.0%+14.4%0.482%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.771,854$7.42M0.0%+10.8%3.043%Search for SEC Filing on Google Icon
8/12/2021Trexquant Investment LP12,226$0.12M0.0%-9.8%0.048%Search for SEC Filing on Google Icon
8/12/2021DRW Securities LLC1,000,000$9.61M0.3%+94.8%3.943%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.7,493$72K0.0%+274.3%0.030%Search for SEC Filing on Google Icon
8/12/2021Ergoteles LLC26,717$0.26M0.0%N/A0.105%Search for SEC Filing on Google Icon
8/11/2021Princeton Capital Management LLC110,282$1.06M0.3%N/A0.435%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.261,514$2.51M0.0%-8.2%1.031%Search for SEC Filing on Google Icon
8/10/2021Fermata Advisors LLC20,400$0.20M0.1%+60.6%0.080%Search for SEC Filing on Google Icon
8/5/2021P.A.W. Capital Corp75,000$0.72M0.6%+17.7%0.296%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP77,283$0.74M0.1%N/A0.305%Search for SEC Filing on Google Icon
8/2/2021Venturi Wealth Management LLC8,273$80K0.0%N/A0.033%Search for SEC Filing on Google Icon
5/19/2021Diametric Capital LP32,868$0.45M0.3%N/A0.130%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC239,678$3.25M0.0%+134.5%0.945%Search for SEC Filing on Google Icon
5/18/2021Cubist Systematic Strategies LLC18,972$0.26M0.0%N/A0.075%Search for SEC Filing on Google Icon
5/18/2021Corriente Advisors LLC1,565,682$21.25M7.8%+16.0%6.173%Search for SEC Filing on Google Icon
5/18/2021Fermata Advisors LLC12,700$0.17M0.1%N/A0.050%Search for SEC Filing on Google Icon
5/17/2021PDT Partners LLC12,209$0.17M0.0%N/A0.048%Search for SEC Filing on Google Icon
5/17/2021HRT Financial LP56,992$0.77M0.0%+186.8%0.225%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.13,947$0.19M0.0%N/A0.055%Search for SEC Filing on Google Icon
5/14/2021Nantahala Capital Management LLC382,553$5.19M0.2%-78.3%1.508%Search for SEC Filing on Google Icon
5/14/2021Gagnon Securities LLC377,976$5.13M0.8%+62.3%1.490%Search for SEC Filing on Google Icon
5/14/2021Stifel Financial Corp13,000$0.18M0.0%N/A0.051%Search for SEC Filing on Google Icon
5/13/2021Trexquant Investment LP13,547$0.18M0.0%N/A0.053%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC64,700$0.88M0.0%+84.9%0.255%Search for SEC Filing on Google Icon
5/13/2021DRW Securities LLC513,400$6.97M0.3%N/A2.024%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.17,696$0.24M0.0%-17.9%0.070%Search for SEC Filing on Google Icon
5/13/2021Carlson Capital L P170,000$2.31M0.1%N/A0.670%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC106,910$1.45M0.0%+11.8%0.422%Search for SEC Filing on Google Icon
5/12/2021JPMorgan Chase & Co.2,002$27K0.0%N/A0.008%Search for SEC Filing on Google Icon
5/12/2021UBS Group AG5,935$81K0.0%-60.9%0.023%Search for SEC Filing on Google Icon
5/12/2021Granite Point Capital Management L.P.210,000$2.85M0.1%N/A0.828%Search for SEC Filing on Google Icon
5/10/2021P.A.W. Capital Corp63,695$0.86M0.8%N/A0.251%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.284,921$3.87M0.0%+1.8%1.123%Search for SEC Filing on Google Icon
5/7/2021University of Texas Texas AM Investment Managment Co.22,066$0.30M0.2%-90.0%0.087%Search for SEC Filing on Google Icon
5/7/2021Meridian Wealth Advisors LLC11,500$0.16M0.1%N/A0.045%Search for SEC Filing on Google Icon
5/7/2021IndexIQ Advisors LLC30,498$0.41M0.0%N/A0.120%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
TFF Pharmaceuticals logo
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's lead drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as cannabidiol substance for the treatment of various epilepsy syndromes, as well as anxiety, insomnia, and various pain; Inhaled SARS-CoV2 Monoclonal Antibody for the treatment of patients with COVID-19 infections; Niclosamide Inhalation Powder to treat tapeworm infections in humans, as well as COVID-19 disease; and other vaccines. The company has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop inhaled SARS-CoV2 monoclonal antibody; and a licensing and collaboration agreement with UNION therapeutics A/S. The company was incorporated in 2018 and is based in Austin, Texas.
Read More on TFF Pharmaceuticals

Today's Range

Now: $0.67
Low: $0.67
High: $0.73

50 Day Range

MA: $0.83
Low: $0.62
High: $0.97

52 Week Range

Now: $0.67
Low: $0.62
High: $7.70

Volume

48,196 shs

Average Volume

169,720 shs

Market Capitalization

$23.42 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Who are the company insiders with the largest holdings of TFF Pharmaceuticals?

TFF Pharmaceuticals' top insider shareholders include:
  1. Harlan F Weisman (CEO)
  2. Aaron GL Fletcher (Director)
  3. Glenn R Mattes (CEO)
  4. Kirk Allen Coleman (CFO)
  5. Zamaneh Mikhak (Insider)
  6. Harlan F Weisman (Director)
  7. Malcolm Fairbairn (Director)
  8. Randy H Thurman (Director)
Learn More about top insider investors at TFF Pharmaceuticals.

Who are the major institutional investors of TFF Pharmaceuticals?

TFF Pharmaceuticals' top institutional investors include:
  1. AIGH Capital Management LLC — 5.00%
  2. DRW Securities LLC — 2.87%
  3. Sepio Capital LP — 0.95%
  4. Millennium Management LLC — 0.55%
  5. UBS Group AG — 0.33%
  6. Princeton Capital Management LLC — 0.29%
Learn More about top institutional investors of TFF Pharmaceuticals stock.

Which institutional investors are selling TFF Pharmaceuticals stock?

Within the last quarter, TFFP stock was sold by these institutional investors:
  1. Princeton Capital Management LLC
  2. Group One Trading L.P.
  3. Simplex Trading LLC

Which institutional investors are buying TFF Pharmaceuticals stock?

In the last quarter, TFFP stock was bought by institutional investors including:
  1. AIGH Capital Management LLC
  2. DRW Securities LLC
  3. Millennium Management LLC
  4. Renaissance Technologies LLC
  5. Two Sigma Investments LP
  6. Sigma Planning Corp
  7. UBS Group AG
  8. Sepio Capital LP
In the previous year, these company insiders have bought TFF Pharmaceuticals stock:
  1. Harlan F Weisman (CEO)
  2. Aaron GL Fletcher (Director)
  3. Glenn R Mattes (CEO)
  4. Kirk Allen Coleman (CFO)
  5. Zamaneh Mikhak (Insider)
  6. Harlan F Weisman (Director)
  7. Malcolm Fairbairn (Director)
Learn More investors buying TFF Pharmaceuticals stock.
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
pixel